New planning bill could be the government’s most important – but will it work in practice?
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
- Science
Gina Kolata
- 0
- 1 minute read
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
